The Gross Margin of Korea Arlico Pharm Co Ltd (260660.KQ) is 52.40%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 52.40% |
| 2023-12-31 | 58.87% |
| 2022-12-31 | 63.74% |
| 2021-12-31 | 62.45% |
| 2020-12-31 | 63.94% |
| 2019-12-31 | 63.45% |
| 2018-12-31 | 61.76% |
| 2017-12-31 | 60.72% |
| 2016-12-31 | 57.00% |
| 2015-12-31 | 52.54% |